Comparisons of brain, uterus, and liver mRNA expression for cytochrome P450s, DNA methyltransferase-1, and catechol-o-methyltransferase; in prepubertal female sprague-dawley rats exposed to a mixture of aryl hydrocarbon receptor agonists

Toxicological Sciences

Volumn 86, Issue 1, 2005, Pages 175-184

  Desaulniers, Daniel ^a   Xiao, G H ^a   Leingartner, K ^a   Chu, I ^a   Musicki, B ^b   Tsang, B K ^b  

^a Environmental Health Center   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Catechol o methyltransferase; DNA methyltransferase; Polychlorinated dibenzodioxins; Polychlorinated dibenzofurans; Rat; Uterus

Indexed keywords

2,3,7,8 TETRABROMODIBENZOFURAN; 2,3,7,8 TETRACHLORODIBENZOFURAN; 3,3',4,4' TETRACHLOROBIPHENYL; 3,3',4,4',5 PENTACHLOROBIPHENYL; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYTOCHROME P450 2B1; DNA METHYLTRANSFERASE 1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; AROMATIC HYDROCARBON RECEPTOR; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BREAST MILK; CONTROLLED STUDY; DNA METHYLATION; ESTROGEN METABOLISM; FEEDING; FEMALE; HUMAN; HYPOTHALAMUS; LASER CAPTURE MICRODISSECTION; LIVER; MILK LEVEL; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PREPUBERTY; PROTEIN EXPRESSION; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUAL MATURITY; SIGNAL TRANSDUCTION; UTERUS; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; BASE SEQUENCE; BRAIN; CATECHOL O-METHYLTRANSFERASE; CYTOCHROME P-450 ENZYME SYSTEM; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA PRIMERS; FEMALE; LIVER; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; UTERUS;

EID: 26944468327     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfi178     Document Type: Article

References (82)

1. Andersen, H. R., Nielsen, J. B., and Grandjean, P. (2000). Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology 144, 121-127.
2. Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., and Vogelstein, B. (2003). Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3, 89-95.
3. Badawi, A. F., Cavalieri, E. L., and Rogan, E. G. (2000). Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2-and 4-hydroxylation of 17β-estradiol in female Sprague-Dawley rats. Carcinogenesis 21, 1593-1599.
4. Beyer, C., Pawlak, J., and Karolczak, M. (2003). Membrane receptors for oestrogen in the brain. J. Neurochem. 87, 545-550.
5. Bombail, V., Moggs, J. G., and Orphanides, G. (2004). Perturbation of epigenetic status by toxicants. Toxicol. Lett. 149, 51-58.
6. Brawer, J. R., Beaudet, A., Desjardins, G. C., and Schipper, H. M. (1993). Minireview. Pathologic effect of estradiol on the hypothalamus. Biol. Reprod. 49, 647-652.
7. Calabrese, E. J., and Baldwin, L. A. (2003). Hormesis: The dose-response revolution. Annu. Rev. Pharmacol. Toxicol. 43, 175-197.
8. Carnell, A. N., and Goodman, J. I. (2003). The long (LINEs) and the short (SINEs) of it: Altered methylation as a precursor to toxicity. Toxicol. Sci. 75, 229-235.
9. Cavalieri, E., Fenkel, K., Liehr, J. G., Rogan, E., and Roy, D. (2000). Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 27, 75-93.
10. Christou, M., Savas, U., Schroeder, S., Shen, X., Thompson, T., Gould, M. N., and Jefcoate, C. R. (1995). Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: Cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol. Cell. Endocrinol. 115, 41-50.
11. Cisneros, F. J. (2004). DNA methylation and male infertility. Frontiers Biosci. 9, 1189-1200.
12. Costa, E., Grayson, D. R., Veldic, M., and Guidotti, A. (2004). Neurochemical basis for an epigenetic vision of synaptic organization. Int. Rev. Neurobiol. 59, 73-91.
13. Desaulniers, D., Cooke, G. M., Leingartner, K., Soumano, K., Cole, J., Yang, J., Wade, M. G., and Yagminas, A. (2005). Effects of postnatal exposure to a mixture of PCBs, p,p′-DDT and p,p′-DDE in prepubertal and adult female Sprague-Dawley rats. Int. J. Toxicol. 24, 1-17.
14. Desaulniers, D., Leingartner, K., Musicki, B., Cole, J., Li, M., Charbonneau, M., and Tsang, B. K. (2004). Effects of postnatal exposure to a mixture of aryl hydrocarbon-receptor agonists on the development of methylnitrosourea-induced mammary tumours in female Sprague-Dawley rat. J. Toxicol. Environ. Health Part A 67, 1-19.
15. Desaulniers, D., Leingartner, K., Musicki, B., Yagminas, A., Xiao, G., Cole, J., Marro, L., Charbonneau, M., and Tsang, B. K. (2003). Effects of postnatal exposure to mixtures of non-ortho-PCBs, PCDDs and PCDFs in prepubertal female rats. Toxicol. Sci. 75, 468-480.
16. Desaulniers, D., Leingartner, K., Russo, J., Perkins, G., Chittim, B. G., Archer, M. C., Wade, M., and Yang, J. (2001). Modulatory effects of neonatal exposure to TCDD, or a mixture of PCBs, p,p′-DDT and p.p′-DDE, on methylnitrosourea-induced mammary tumor development in the rat. Environ. Health Perspect. 109, 739-747.
17. Dewailly, E., Nantel, A., Bruneau, S., Laliberte, C., Ferron, L., and Gingras, S. (1992). Breast milk contamination by PCDDs, PCDFs and PCBs in arctic Quebec: A preliminary assessment. Chemosphere 25, 1245-1249.
18. Dubey, R. K., Tofovic, S. P., and Jackson, E. K. (2004). Cardiovascular pharmacology of estradiol metabolites. J. Pharmacol. Exp. Ther. 308, 403-409.
19. Eden, A., Gaudet, F., Waghmare, A., and Jaenisch, R. (2003). Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455.
20. Egger, G., Liang, G., Aparicio, A., and Jones, P. A. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463.
21. Feeley, M., and Brouwer, A. (2000). Health risks to infants from exposure to PCBs, PCDDs and PCDFs. Food Addit. Contam. 17, 325-333.
22. Frank, R., Rasper, J., Smout, M. S., and Braun, H. E. (1988). Organochlorine residues in adipose tissues, blood and milk from Ontario residents, 1976-1985. Can. J. Public Health 79, 150-158.
23. Garner, C. E., Burka, L. T., Etheridge, A. E., and Matthews, H. B. (2000). Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens. Toxicol. Appl. Pharmacol. 162, 115-123.
24. Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., and Jaenisch, R. (2003). Induction of tumors in mice by genomic hypomethylation. Science 300, 489-492.
25. Goldstein, D. S., Eisenhofer, G., and Kopin, I. J. (2003). Sources and significance of plasma levels of catechols and their metabolites in humans. J. Pharmacol. Exp. Ther. 305, 800-811.
26. Granberg, L., Ostergren, A., Brandt, I., and Brittebo, E. B. (2003). CYP1A1 and CYP1B1 in blood-brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz(a)anthracene in endothelial cells. Drug Metab. Dispos. 31, 259-265.
27. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. (1996). 17β-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. U.S.A. 93, 9776-9781.
28. Hersey, R. M., Lloyd, T., Maclusky, N. J., and Weisz, J. (1982). The catechol estrogen, 2-hydroxyestradiol-17 alpha, is formed from estradiol-17 alpha by hypothalamic tissue in vitro and inhibits tyrosine hydroxylase. Endocrinology 111, 1734-1736.
29. Ivanova, T., and Beyer, C. (2000). Ontogenetic expression and sex differences of aromatase and estrogen receptor-alpha/beta mRNA in the mouse hippocampus. Cell Tissue Res. 300, 231-237.
30. Ivanova, T., and Beyer, C. (2003). Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J. Neurobiol. 54, 638-647.
31. Jefcoate, C. R., Liehr, J. G., Santen, R. J., Sutter, T. R., Yager, J. D., Yue, W., Santner, S. J., Tekmal, R., Demers, L., Pauley, R. et al. (2000). Tissue-specific synthesis and oxidative metabolism of estrogens. J. Natl. Cancer Inst. Monogr. 27, 95-112.
32. Kajta, M., and Beyer, C. (2003). Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocrine 21, 3-9.
33. Kaneda, M., Okano, M., Hata, K., Sado, T., Tsujimoto, N., Li, E., and Sasaki, H. (2004). Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429, 900-903.
34. Kanno, J., Onyon, L., Haseman, J., Fenner-Crisp, P., Ashby, J., and Owens, W. (2001). The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: Phase 1. Environ. Health Perspect. 109, 785-794.
35. Kanno, J., Onyon, L., Peddada, S., Ashby, J., Jacob, E., and Owens, W. (2003a). The OECD program to validate the rat uterotrophic bioassay. Phase 2: Coded single-dose studies. Environ. Health Perspect. 111, 1550-1558.
36. Kanno, J., Onyon, L., Peddada, S., Ashby, J., Jacob, E., and Owens, W. (2003b). The OECD program to validate the rat uterotrophic bioassay. Phase 2: Dose-response studies. Environ. Health Perspect. 111, 1530-1549.
37. Kishikawa, S., Murata, T., Ugai, H., Yamazaki, T., and Yokoyama, K. K. (2003). Control elements of Dnmt1 gene are regulated in a cell-cycle dependent manner. Nucleic Acids Res. Suppl. 307-308.
38. Ko, Y. G., Nishino, K., Hattori, N., Arai, Y., Tanaka, S., and Shiota, K. (2005). Stage-by-stage change in DNA methylation status of DNA methyltransferase 1 (Dnmt1) locus during mouse early development. J. Biol. Chem. 280, 9627-34.
39. Li, K. M., Todorovic, R., Devanesan, P., Higginbotham, S., Kofeler, H., Ramanathan, R., Gross, M. L., Rogan, E. G., and Cavalieri, E. L. (2004). Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25, 289-297.
40. Li, M.-H., and Hansen, L. G. (1997). Consideration of enzyme and endocrine interactions in the risk assessment of PCBs. Rev. Toxicol. 1, 71-156.
41. Margot, J. B., Ehrenhofer-Murray, A. E., and Leonhardt, H. (2003). Interactions within the mammalian DNA methyltransferase family. BMC Mol. Biol. 4, 7.
42. Mayes, B. A., McConnell, E. E., Neal, B. H., Brunner, M. J., Hamilton, S. B., Sullivan, T. M., Peters, A. C., Ryan, M. J., Toft, J. D., Singer, A. W. et al. (1998). Comparative carcinogenicity in Sprague-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260. Toxicol. Sci. 41, 62-76.
43. Moggs, J. G., and Orphanides, G. (2004). The role of chromatin in molecular mechanisms of toxicity. Toxicol. Sci. 80, 218-224.
44. Murray, G. I., Melvin, W. T., Greenlee, W. E, and Burke, M. D. (2001). Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41, 297-316.
45. Nayyar, T., Zawia, N. H., and Hood, D. B. (2002). Transplacental effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the temporal modulation of Sp1 DNA binding in the developing cerebral cortex and cerebellum. Exp. Toxicol. Pathol. 53, 461-468.
46. O'Connor, J. C., Cook, J. C., Marty, M. S., Davis, L. G., Kaplan, A. M., and Carney, E. W. (2002). Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs). Crit. Rev. Toxicol. 32, 521-549.
47. Oakes, C. C., Smiraglia, D. J., Plass, C., Trasler, J. M., and Robaire, B. (2003). Aging results in hypermethylation of ribosomal DNA in sperm and liver of male rats. Proc. Natl. Acad. Sci. U.S.A. 100, 1775-1780.
48. Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P. et al. (2003). Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423, 545-550.
49. Owens, W., Ashby, J., Odum, J., and Onyon, L. (2003). The OECD program to validate the rat uterotrophic bioassay. Phase 2: Dietary phytoestrogen analyses. Environ. Health Perspect. 111, 1559-1567.
50. Owens, W., and Koeter, H. B. (2003). The OECD program to validate the rat uterotrophic bioassay: An overview. Environ. Health Perspect. 111, 1527-1529.
51. Paria, B. C., Lim, H., Wang, X. N., Liehr, J., Das, S. K., and Dey, S. K. (1998). Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology 139, 5235-5246.
52. Pinzone, J. J., Stevenson, H., Strobl, J. S., and Berg, P. E. (2004). Molecular and cellular determinants of estrogen receptor alpha expression. Mol. Cell. Biol. 24, 4605-4612.
53. Pogribny, I., Raiche, J., Slovack, M., and Kovalchuk, O. (2004). Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes. Biochem. Biophys. Res. Commun. 320, 1253-1261.
54. Raab, H., Karolczak, M., Reisert, I., and Beyer, C. (1999). Ontogenetic expression and splicing of estrogen receptor-alpha and beta mRNA in the rat midbrain. Neurosci. Lett. 275, 21-24.
55. Ray, S. S., and Swanson, H. I. (2004). Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a. J. Biol. Chem. 279, 27187-27193.
56. Reik, W., Dean, W., and Walter, J. (2001). Epigenetic reprogramming in mammalian development. Science 293, 1089-1093.
57. Rhee, I., Bachman, K. E., Park, B. H., Jair, K. W., Yen, R. W., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W. et al. (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552-556.
58. Romkes, M., Piskorska-Pliszczynska, J., and Safe, S. (1987). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. Toxicol. Appl. Pharmacol. 87, 306-314.
59. Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). C.R.C. Crit. Rev. Toxicol. 21, 51-88.
60. Safe, S., Astroff, B., Harris, M., Zacharewski, T., Dickerson, R., Romkes, M., and Biegel, L. (1991). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: Characterization and mechanism of action. Pharmacol. Toxicol. 69, 400-409.
61. Safe, S. H. (1999). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related environmental antiestrogens: Characterization and mechanism of action. In Endocrine Disruptors: Effects on Male and Female Reproductive Systems (Naz, R. K., Ed.), pp. 187-221. CRC Press, Boca Raton, FL.
62. Saghir, S. A., Hansen, L. G., Holmes, K. R., and Kodavanti, P. R. (2000). Differential and non-uniform tissue and brain distribution of two distinct 14C-hexachlorobiphenyls in wearding rats. Toxicol. Sci. 54, 60-70.
63. Saghir, S. A., Koritz, G. D., and Hansen, L. G. (1999). Short term distribution, metabolism, and excretion of 2,2′,5-tri, 2,2′,4,4′-tetra-, and 3,3′,4,4′-tetrachlorobiphenyls in prepubertal rats. Arch. Environ. Contam. Toxicol. 36, 213-220.
64. SAS Institute Inc (1998). IMP Statistics and Graphics Guide, Version 3, pp. 1-593. SAS Institute Inc, Cary, NC.
65. Schantz, S. L., Widholm, J. J., and Rice, D. C. (2003). Effects of PCB exposure on neuropsychological function in children. Environ. Health Perspect. 111, 357-576.
66. Seeger, H., Huober, J., Wallwiener, D., and Mueek, A. O. (2004). Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen. Horm. Metab. Res. 36, 277-280.
67. Solomon, G. M., and Weiss, P. M. (2002). Chemical contaminants in breast milk: Time trends and regional variability. Environ. Health Perspect. 110, A339-A347.
68. Spink, D. C., Katz, B. H., Hussain, M. M., Pentecost, B. T., Cao, Z., and Spink, B. C. (2003). Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 24, 1941-1950.
69. Spreafico, E., Bettini, E., Pollio, G., and Maggi, A. (1992). Nucleotide sequence of estrogen receptor cDNA from Sprague-Dawley rat. Eur. J. Pharmacol. 227, 353-356.
70. Tenhunen, J., Salminen, M., Jalanko, A., Ukkonen, S., and Ulmanen, I. (1993). Structure of the rat catechol-O-methyltransferase gene: Separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. DNA Cell Biol. 12, 253-263.
71. Tofovic, S. P., Dubey, R. K., and Jackson, E. K. (2001). 2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats. J. Pharmacol. Exp. Ther. 299, 973-977.
72. Upadhya, S. C., Chinta, S. J., Pai, H. V., Boyd, M. R., and Ravindranath, V. (2002). Toxicological consequences of differential regulation of cytochrome P450 isoforms in rat brain regions by phenobarbital. Arch. Biochem. Biophys. 399, 56-65.
73. Van den Berg, M., Birnbaum, L., Bosveld, A. T. C., Brunstrom, B., Cook, P., Feeley, M., Giesy, J. P., Hanberg, A., Hasegawa, R., Kennedy, S. W. et al. (1998). Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 106, 775-792.
74. Weiss, B. (2002). Sexually dimorphic nonreproductive behaviors as indicators of endocrine disruption. Environ. Health Perspect. 110 (Suppl 3), 387-391.
75. White, T. E. K., Rucci, G., Liu, Z., and Gasiewicz, T. A. (1995). Weanling female Sprague-Dawley rats are not sensitive to the antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Appl. Pharmacol. 133, 313-320.
76. Wolffe, A. P., and Matzke, M. A. (1999). Epigenetics: Regulation through repression. Science 286, 481-486.
77. Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., and Safe, S. (2003). The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Mol. Cell. Biol. 23, 1843-1855.
78. Wu, Q., Ohsako, S., Ishimura, R., Suzuki, J. S., and Tohyama, C. (2004). Exposure of mouse preimplantation embryos to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the methylation status of imprinted genes H19 and Igf2. Biol. Reprod. 70, 1790-1797.
79. Wyde, M. E., Wong, V. A., Kim, A. H., Lucier, G. W., and Walker, N. J. (2001). Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent. Chem. Res. Toxicol. 14, 849-855.
80. Yasunaga, J., Taniguchi, Y., Nosaka, K., Yoshida, M., Satou, Y., Sakai, T., Mitsuya, H., and Matsuoka, M. (2004). Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res. 64, 6002-6009.
81. Zacharia, L. C., Piche, C. A., Fielding, R. M., Holland, K. M., Allison, S. D., Dubey, R. K., and Jackson, E. K. (2004). 2-Hydroxyestradiol is a prodrug of 2-methoxyestradiol. J. Pharmacol. Exp. Ther 309, 1093-1097.
82. Zhu, B. T. (2002). Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: Importance in pathophysiology and pathogenesis. Curr. Drug Metab. 3, 321-349.